EUR-Lex Search results

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Search Results

Query: ((DN = "32016D0135" AND DD <= 05/07/2022) OR (RESOURCE_LEGAL_CORRECTS_RESOURCE_LEGAL = "32016D0135" AND DD >= 29/01/2016 AND DD < 05/07/2022 AND (EMBEDDED_ACT_CONSOLIDATED_DATE > 29/01/2016 OR EMBEDDED_ACT_CONSOLIDATED_DATE = NULL)) OR ((RESOURCE_LEGAL_REPEALS_RESOURCE_LEGAL = "32016D0135" OR RESOURCE_LEGAL_IMPLICITLY_REPEALS_RESOURCE_LEGAL = "32016D0135" OR RESOURCE_LEGAL_RENDERS_OBSOLETE_RESOURCE_LEGAL = "32016D0135" OR RESOURCE_LEGAL_REPLACES_RESOURCE_LEGAL = "32016D0135" OR RESOURCE_LEGAL_SUSPENDS_RESOURCE_LEGAL = "32016D0135" OR RESOURCE_LEGAL_PARTIALLY_SUSPENDS_RESOURCE_LEGAL = "32016D0135" OR RESOURCE_LEGAL_AMENDS_RESOURCE_LEGAL = "32016D0135") AND DD > 29/01/2016 AND DD <= 05/07/2022)) AND (EMBEDDED_WHE_EXPRESSION_LG=ENG), Search language: English

Commission Implementing Regulation (EU) 2017/1376 of 25 July 2017 renewing the approval of warfarin as an active substance for use in biocidal products of product-type 14 (Text with EEA relevance. )

C/2017/5079

In force

CELEX number:
32017R1376
Form:
Implementing regulation
Responsible body:
SANTE
Author:
European Commission, Directorate-General for Health and Food Safety
Date of document:
25/07/2017; Date of adoption

Commission Implementing Decision (EU) 2016/135 of 29 January 2016 postponing the expiry date of approval of flocoumafen, brodifacoum and warfarin for use in biocidal products for product-type 14 (Text with EEA relevance)

No longer in force

CELEX number:
32016D0135
Form:
Implementing decision
Author:
European Commission
Date of document:
29/01/2016; Date of adoption